Composition
- Active ingredients
- METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableThis page
- METOCLOPRAMIDE HYDROCHLORIDE EQ 10MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA017862-004 · Discontinued
- METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · SolutionNDA018821-001 · Discontinued
- METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE · TabletNDA017854-002 · Prescription
- METOCLOPRAMIDE HYDROCHLORIDE EQ 10MG BASE · TabletNDA017854-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA017862.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Reglan
- Active substance
- metoclopramide hydrochloride
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Hikma
- Status
- Discontinued
- FDA approval
- 7 Feb 1979
- Application
- NDA017862-001